News

Pharmabiz5h

CSIR-CFTRI, completes Phase II collection of Phenome India Health Cohort project

CSIR-CFTRI, completes Phase II collection of Phenome India Health Cohort project: Our Bureau, Bengaluru Tuesday, August 12, ...
Pharmabiz43m

Cystic fibrosis treatment brings new hope for patients

The National Institute for Health and Care Excellence (NICE) has approved a new treatment for cystic fibrosis (CF), making it available to hundreds of children and adults with the condition in England ...
Pharmabiz2h

Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth

Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth: Our Bureau, Bengaluru Tuesday, August 12, 2025, 15:30 Hrs [IST] Akums Drugs ...
Pharmabiz1h

US FDA grants fast track designation to NRx Pharma’s NRX-100 for suicidal ideation in patients with depression, including bipolar depression

US FDA grants fast track designation to NRx Pharma’s NRX-100 for suicidal ideation in patients with depression, including bipolar depression: Wilmington, Delaware Tuesday, Augus ...
Pharmabiz2h

Asian Institute of Nephrology & Urology inaugurates flagship hospital in Banjara Hills, Hyderabad

Asian Institute of Nephrology & Urology inaugurates flagship hospital in Banjara Hills, Hyderabad: Our Bureau, Mumbai Tuesday, August 12, 2025, 15:00 Hrs [IST] Asian Institute of ...
Pharmabiz3h

Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease

Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease: Basel Tuesday, August 12, 2025, 14:00 Hrs [IST] Novartis announced ...
Pharmabiz4h

Orchestra BioMed announces rollout of US FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibility

Orchestra BioMed announces rollout of US FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibility: New Hope, Pennsylvania Tuesday, Au ...
Pharmabiz4h

Rainbow acquires major stake in Pratiksha Hospital, Guwahati for Rs. 171 crore, to expands national footprint

Rainbow acquires major stake in Pratiksha Hospital, Guwahati for Rs. 171 crore, to expands national footprint: Our Bureau, Bengaluru Tuesday, August 12, 2025, 12:45 Hrs [IST] Rain ...
Pharmabiz3h

Lupin partners with Sandoz to market & commercialize biosimilar ranibizumab across multiple regions

Lupin partners with Sandoz to market & commercialize biosimilar ranibizumab across multiple regions: Our Bureau, Mumbai Tuesday, August 12, 2025, 13:45 Hrs [IST] Global Pharma maj ...
Pharmabiz5h

Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD

Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD: Rancho Cucamonga, California Tuesday, August 12, 2025, ...
Pharmabiz6h

WuXi Biologics launches HEK 293 Stable cell line platform WuXia293Stable for development and manufacturing of difficult-to-express molecules

WuXi Biologics launches HEK 293 Stable cell line platform WuXia293Stable for development and manufacturing of difficult-to-express molecules: Shanghai Tuesday, August 12, 2025, 11 ...
Pharmabiz7h

US FDA accepts for priority review GSK’s sNDA for gepotidacin for oral treatment of uncomplicated urogenital gonorrhoea

US FDA accepts for priority review GSK’s sNDA for gepotidacin for oral treatment of uncomplicated urogenital gonorrhoea: London, UK Tuesday, August 12, 2025, 10:00 Hrs [IST] GSK ...